Literature DB >> 24504402

Drug-resistant tuberculosis: a new shot on goal.

Carl Nathan1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24504402     DOI： 10.1038/nm.3470

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  12 in total

1.  The emerging threat of untreatable gonococcal infection.

Authors:  Gail A Bolan; P Frederick Sparling; Judith N Wasserheit
Journal:  N Engl J Med       Date:  2012-02-09       Impact factor: 91.245

2.  Antibiotics at the crossroads.

Authors:  Carl Nathan
Journal:  Nature       Date:  2004-10-21       Impact factor: 49.962

Review 3.  Scaling up interventions to achieve global tuberculosis control: progress and new developments.

Authors:  Mario Raviglione; Ben Marais; Katherine Floyd; Knut Lönnroth; Haileyesus Getahun; Giovanni B Migliori; Anthony D Harries; Paul Nunn; Christian Lienhardt; Steve Graham; Jeremiah Chakaya; Karin Weyer; Stewart Cole; Stefan H E Kaufmann; Alimuddin Zumla
Journal:  Lancet       Date:  2012-05-19       Impact factor: 79.321

4.  High-sensitivity MALDI-MRM-MS imaging of moxifloxacin distribution in tuberculosis-infected rabbit lungs and granulomatous lesions.

Authors:  Brendan Prideaux; Véronique Dartois; Dieter Staab; Danielle M Weiner; Anne Goh; Laura E Via; Clifton E Barry; Markus Stoeckli
Journal:  Anal Chem       Date:  2011-02-18       Impact factor: 6.986

Review 5.  Fresh approaches to anti-infective therapies.

Authors:  Carl Nathan
Journal:  Sci Transl Med       Date:  2012-06-27       Impact factor: 17.956

6.  The future of antibiotics and resistance.

Authors:  Brad Spellberg; John G Bartlett; David N Gilbert
Journal:  N Engl J Med       Date:  2013-01-24       Impact factor: 91.245

7.  Resuscitation-promoting factors reveal an occult population of tubercle Bacilli in Sputum.

Authors:  Galina V Mukamolova; Obolbek Turapov; Joanne Malkin; Gerrit Woltmann; Michael R Barer
Journal:  Am J Respir Crit Care Med       Date:  2009-10-29       Impact factor: 21.405

8.  Para-aminosalicylic acid acts as an alternative substrate of folate metabolism in Mycobacterium tuberculosis.

Authors:  Sumit Chakraborty; Todd Gruber; Clifton E Barry; Helena I Boshoff; Kyu Y Rhee
Journal:  Science       Date:  2012-11-01       Impact factor: 47.728

Review 9.  Natural history of tuberculosis: duration and fatality of untreated pulmonary tuberculosis in HIV negative patients: a systematic review.

Authors:  Edine W Tiemersma; Marieke J van der Werf; Martien W Borgdorff; Brian G Williams; Nico J D Nagelkerke
Journal:  PLoS One       Date:  2011-04-04       Impact factor: 3.240

10.  Spectinamides: a new class of semisynthetic antituberculosis agents that overcome native drug efflux.

Authors:  Richard E Lee; Julian G Hurdle; Jiuyu Liu; David F Bruhn; Tanja Matt; Michael S Scherman; Bernd Meibohm; Erik C Böttger; Anne J Lenaerts; Pavan K Vaddady; Zhong Zheng; Jianjun Qi; Rashid Akbergenov; Sourav Das; Dora B Madhura; Chetan Rathi; Ashit Trivedi; Cristina Villellas; Robin B Lee; Samanthi L Waidyarachchi; Dianqing Sun; Michael R McNeil; Jose A Ainsa; Helena I Boshoff; Mercedes Gonzalez-Juarrero
Journal:  Nat Med       Date:  2014-01-26       Impact factor: 53.440
View more
  2 in total

1.  Mechanism of MenE inhibition by acyl-adenylate analogues and discovery of novel antibacterial agents.

Authors:  Joe S Matarlo; Christopher E Evans; Indrajeet Sharma; Lubens J Lavaud; Stephen C Ngo; Roger Shek; Kanagalaghatta R Rajashankar; Jarrod B French; Derek S Tan; Peter J Tonge
Journal:  Biochemistry       Date:  2015-10-15       Impact factor: 3.162

Review 2.  Central carbon metabolism remodeling as a mechanism to develop drug tolerance and drug resistance in Mycobacterium tuberculosis.

Authors:  Hyungjin Eoh; Rachel Liu; Juhyeon Lim; Jae Jin Lee; Philip Sell
Journal:  Front Cell Infect Microbiol       Date:  2022-08-22       Impact factor: 6.073
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.